Skip to main content

Want a detailed portfolio tracker?

Intensity Therapeutics (INTS) P/E (2023 - 2026)

Intensity Therapeutics (INTS) P/E from Oct 2, 2023 to Jul 21, 2026. The TTM Intensity Therapeutics (INTS) P/E is -0.74. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Intensity Therapeutics (INTS)

YearP/EChange
2026-0.74-24.44%
2025-0.98-35.44%
2024-1.52-96.99%
2023-50.42N/A

Comparison Intensity Therapeutics (INTS) P/E with competitors

Intensity Therapeutics (INTS) P/E is -0.74.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.23%
NBYStablecoin Development Corp0.00-100.58%
ENLVEnlivex Ltd0.07-110.12%
FGENFibroGen Inc0.24-132.47%
CHRSCoherus Biosciences Inc0.85-214.77%
FBIOFortress Biotech Inc0.95-228.37%
ORMPOramed Pharmaceuticals Inc1.50-303.31%
AGENAgenus Inc3.01-507.09%
VXRTVaxart Inc3.55-580.15%
CRMDCorMedix Inc3.63-590.79%
CVACCureVac N.V.4.45-701.33%
GLPGGalapagos NV4.86-757.23%
SRPTSarepta Therapeutics Inc4.88-760.36%
ABEOAbeona Therapeutics Inc5.39-828.73%
ABUSArbutus Biopharma Corp5.60-856.88%
ZVRAZevra Therapeutics Inc5.89-896.32%
SPROSpero Therapeutics Inc6.23-942.48%
CGENCompugen Ltd6.31-954.04%
RIGLRigel Pharmaceuticals6.87-1029.53%
SLXNSilexion Therapeutics Corp7.30-1086.89%
OMEROmeros Corporation9.26-1352.36%
AUPHAurinia Pharmaceuticals Inc9.58-1396.49%
PLXProtalix BioTherapeutics Inc10.89-1573.15%
ACADAcadia Pharmaceuticals Inc11.73-1686.43%
TBPHTheravance Biopharma Inc12.26-1758.61%
ADMAAdma Biologics Inc12.42-1779.72%
HRMYHarmony Biosciences Holdings Inc13.82-1969.36%
SABSSAB Biotherapeutics Inc14.14-2012.11%
NAGENiagen Bioscience Inc14.82-2104.34%
INCYIncyte Corp15.82-2240.21%
REGNRegeneron Pharmaceuticals Inc15.86-2244.82%
PBYIPuma Biotechnology Inc17.32-2442.18%
CPRXCatalyst Pharmaceuticals Inc17.44-2458.89%
EXELExelixis Inc17.54-2472.25%
TGTXTG Therapeutics Inc18.97-2665.41%
MDXGMimedx Group Inc20.55-2880.00%
XOMAXOMA Royalty Corp22.87-3194.18%
ARGXArgen X SE24.30-3386.71%
CTMXCytomX Therapeutics Inc24.82-3457.47%
XOMAOXOMA Royalty Corp25.34-3528.31%
HALOHalozyme Therapeutics Inc25.62-3566.03%
XOMAPXOMA Royalty Corp25.67-3572.31%
VRTXVertex Pharmaceuticals Inc27.99-3886.75%
RPRXRoyalty Pharma plc - Class A28.69-3980.47%
SLNOSoleno Therapeutics Inc29.02-4024.81%
ASNDAscendis Pharma A/S30.09-4169.57%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5228.23%
APLSApellis Pharmaceuticals Inc39.02-5378.27%
BMRNBiomarin Pharmaceutical Inc42.21-5809.86%
KRYSKrystal Biotech Inc45.34-6233.46%
ONCBeiGene Ltd69.54-9506.51%
PHARPharming Group N.V.75.03-10248.47%
TECHBio-Techne Corp101.96-13891.58%
VCELVericel Corp109.92-14968.71%
ALNYAlnylam Pharmaceuticals Inc117.96-16056.76%
GMABGenmab140.29-19076.68%
TLXTelix Pharmaceuticals Ltd162.15-22033.89%
CORTCorcept Therapeutics Inc212.86-28892.55%